Combination of amlodipine besylate and olmesartan medoxomil provides greater reduction in blood pressure compared with monotherapy in subjects with and without diabetes

被引：0

作者：

Bakris, G. ^{[1
]}

Karki, S. ^{[2
]}

Lee, J. ^{[2
]}

Heyrman, R. ^{[2
]}

机构：

[1] Univ Chicago, Sch Med, Chicago, IL 60637 USA

[2] Daiichi Sankyo Inc, Parsippany, NJ USA

来源：

JOURNAL OF HYPERTENSION | 2008年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S190 / S190

页数：1

共 50 条

[31] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2013, 30 (12) : 1086 - 1099
[32] A randomized, double-blind, placebo-controlled. factorial study evaluating the efficacy and safety of co-administration of amlodipine besylate plus olmesartan medoxomil compared to monotherapy in patients with mild to severe hypertension
Chrysant, S. G.
Melino, M.
Karki, S.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2008, 26 : S376 - S376
[33] The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy
Chrysant, Steven G.
Sugimoto, Daniel H.
Lefkowitz, Marty
Salko, Thomas
Khan, Mahmudul
Arora, Vipin
Shi, Victor
BLOOD PRESSURE, 2007, 16 : 10 - 17
[34] Erratum to: The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Luis Ruilope
Angie Schaefer
Advances in Therapy, 2014, 31 : 243 - 243
[35] Erratum to: The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Luis Ruilope
Angie Schaefer
Advances in Therapy, 2015, 32 : 184 - 185
[36] Erratum to: The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Luis Ruilope
Angie Schaefer
Advances in Therapy, 2014, 31 : 472 - 472
[37] Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination TherapyPost Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study
Jean-Jacques Mourad
Sylvain Le Jeune
Clinical Drug Investigation, 2009, 29 : 419 - 425
[38] Combination of amlodipine plus olmesartan medoxomil (OM) is effective and safe with long term dosing while treating patients (pts) to blood pressure (BP) goal
Chrysant, S. G.
Oparil, S.
Bakris, G.
Melino, M.
Karki, S.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2008, 26 : S374 - S374
[39] THE EFFECTS OF AN AMLODIPINE (AML)/OLMESARTAN MEDOXOMIL (OM)-BASED TREATMENT ALGORITHM ON 24-HOUR BLOOD PRESSURE (BP) IN BLACK AND HISPANIC PATIENTS UNCONTROLLED ON PRIOR MONOTHERAPY
Nesbitt, S. D.
Weir, M. R.
Shojaee, A.
Wang, I.
ETHNICITY & DISEASE, 2011, 21 (04) : S7 - S7
[40] Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy Post Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study
Mourad, Jean-Jacques
Le Jeune, Sylvain
CLINICAL DRUG INVESTIGATION, 2009, 29 (06) : 419 - 425

← 1 2 3 4 5 →